$1.19
+0.02 (+1.71%)
Open$1.20
Previous Close$1.17
Day High$1.20
Day Low$1.12
52W High$1.66
52W Low$0.56
Volume—
Avg Volume1.05M
Market Cap19.46M
P/E Ratio—
EPS$-0.59
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+3,644.5% upside
Current
$1.19
$1.19
Target
$44.56
$44.56
$28.75
$44.56 avg
$50.07
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 60.43M | 53.33M | 1.67M |
| Net Income | -15,266,363 | -12,125,784 | 470.0K |
| Profit Margin | -25.3% | -24.0% | 28.1% |
| EBITDA | -16,298,073 | -13,664,433 | 856.8K |
| Free Cash Flow | — | — | 585.2K |
| Rev Growth | +13.3% | +13.3% | +24.3% |
| Debt/Equity | 0.44 | 0.44 | 0.16 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,150.99 | -1.64% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.17 | -0.01% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $148.08 | -1.88% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $28.18 | +0.90% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $61.15 | -1.77% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.61 | -1.72% | 11.5 | 30.15B |